Replimune Group
REPL
REPL
140 hedge funds and large institutions have $949M invested in Replimune Group in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 35 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.9% less ownership
Funds ownership: 96.88% → 94.98% (-1.9%)
26% less capital invested
Capital invested by funds: $1.29B → $949M (-$342M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
140
Holding in Top 10
4
Calls
$193K
Puts
$49K
Top Buyers
| 1 | +$25.2M | |
| 2 | +$16.9M | |
| 3 | +$11M | |
| 4 |
BlackRock
New York
|
+$10.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.87M |
Top Sellers
| 1 | -$18M | |
| 2 | -$11.9M | |
| 3 | -$10.4M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$5.5M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$4.32M |